Literature DB >> 34788501

Galacto-Oligosaccharide Supplementation Modulates Pathogen-Commensal Competition between Streptococcus agalactiae and Streptococcus salivarius.

Rebecca E Moore1, Harrison C Thomas1,2, Shannon D Manning3, Jennifer A Gaddy4,5, Steven D Townsend1.   

Abstract

The members of the infant microbiome are governed by feeding method (breastmilk vs. formula). Regardless of the source of nutrition, a competitive growth advantage can be provided to commensals through prebiotics - either human milk oligosaccharides (HMOs) or plant oligosaccharides that are supplemented into formula. To characterize how prebiotics modulate commensal - pathogen interactions, we have designed and studied a minimal microbiome where a pathogen, Streptococcus agalactiae engages with a commensal, Streptococcus salivarius. We discovered that while S. agalactiae suppresses the growth of S. salivarius via increased lactic acid production, galacto-oligosaccharides (GOS) supplementation reverses the effect. This result has major implications in characterizing how single species survive in the gut, what niche they occupy, and how they engage with other community members.
© 2021 Wiley-VCH GmbH.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34788501      PMCID: PMC9197176          DOI: 10.1002/cbic.202100559

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.461


  34 in total

Review 1.  Birth Mode, Breastfeeding, Pet Exposure, and Antibiotic Use: Associations With the Gut Microbiome and Sensitization in Children.

Authors:  Haejin Kim; Alexandra R Sitarik; Kimberley Woodcroft; Christine Cole Johnson; Edward Zoratti
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

Review 2.  The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: A systematic review.

Authors:  T H Dierikx; D H Visser; M A Benninga; A H L C van Kaam; N K H de Boer; R de Vries; J van Limbergen; T G J de Meij
Journal:  J Infect       Date:  2020-05-07       Impact factor: 6.072

Review 3.  Galactooligosaccharides: novel components of designer foods.

Authors:  Vikas Sangwan; S K Tomar; R R B Singh; A K Singh; Babar Ali
Journal:  J Food Sci       Date:  2011-04-13       Impact factor: 3.167

4.  Prevention of perinatal group B streptococcal disease: updated CDC guideline.

Authors:  Colleen K Cagno; Jessie M Pettit; Barry D Weiss
Journal:  Am Fam Physician       Date:  2012-07-01       Impact factor: 3.292

5.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

Review 6.  Understanding the regulation of Group B Streptococcal virulence factors.

Authors:  Lakshmi Rajagopal
Journal:  Future Microbiol       Date:  2009-03       Impact factor: 3.165

7.  Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.

Authors:  Ghalia Kaci; Denise Goudercourt; Véronique Dennin; Bruno Pot; Joël Doré; S Dusko Ehrlich; Pierre Renault; Hervé M Blottière; Catherine Daniel; Christine Delorme
Journal:  Appl Environ Microbiol       Date:  2013-11-22       Impact factor: 4.792

Review 8.  Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.

Authors:  Sarah Shabayek; Barbara Spellerberg
Journal:  Front Microbiol       Date:  2018-03-14       Impact factor: 5.640

Review 9.  Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.

Authors:  Yvan Vandenplas; Bernard Berger; Virgilio Paolo Carnielli; Janusz Ksiazyk; Hanna Lagström; Manuel Sanchez Luna; Nathalia Migacheva; Jean-Marc Mosselmans; Jean-Charles Picaud; Mike Possner; Atul Singhal; Martin Wabitsch
Journal:  Nutrients       Date:  2018-08-24       Impact factor: 5.717

10.  A Solution to Antifolate Resistance in Group B Streptococcus: Untargeted Metabolomics Identifies Human Milk Oligosaccharide-Induced Perturbations That Result in Potentiation of Trimethoprim.

Authors:  Schuyler A Chambers; Rebecca E Moore; Kelly M Craft; Harrison C Thomas; Rishub Das; Shannon D Manning; Simona G Codreanu; Stacy D Sherrod; David M Aronoff; John A McLean; Jennifer A Gaddy; Steven D Townsend
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.